Re-188 lipiodol in hepatocellular carcinoma with portal vein thrombosis: a pilot study using novel chelating agent N-DEDC and its comparison with (A)HDD
Sign Up to like & getrecommendations! Published in 2024 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001840
Abstract: Objective Hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) have limited therapeutic options, Re-188 lipiodol transarterial therapy being one of them. We aimed to assess the safety and efficacy of Re-188 lipiodol exclusively in HCC… read more here.
Keywords: dedc; hdd; response; hepatocellular carcinoma ... See more keywords